Peripherally mediated opioid combination therapy in mouse and pig

Area of Science:

• Pharmacology
• Neuroscience
• Pain Management

Background:

• The opioid epidemic necessitates analgesics with reduced abuse potential.
• Targeting both μ- and δ-opioid receptors offers synergistic pain relief.
• Loperamide (μ-agonist) and oxymorphindole (δ-agonist) combinations show promise.

Purpose of the Study:

• To evaluate the analgesic synergy of loperamide and oxymorphindole (or N-benzyl-oxymorphindole) in preclinical models.
• To assess the efficacy and safety of these combinations in a large animal model.

Main Methods:

• Tested loperamide and oxymorphindole/N-benzyl-oxymorphindole combinations in mouse hyperalgesia models.
• Compared analgesic effects and side effects of these combinations versus morphine in pigs.

Main Results:

• Significant analgesic synergy observed between loperamide and oxymorphindole/N-benzyl-oxymorphindole in mice.
• Both combinations demonstrated superior potency and efficacy compared to morphine in pigs.
• No adverse effects on respiration or heart rate were noted in pigs.

Conclusions:

• Combined μ- and δ-opioid receptor agonists (loperamide with OMI/BOMI) effectively manage incisional pain.
• These novel combinations offer potent analgesia with a favorable safety profile in preclinical models.
• Potential for reduced opioid burden and side effects in clinical pain management.